Portfolio company
PredictaMed
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops an AI platform for healthcare providers to identify at-risk patients and accelerate the diagnosis of autoimmune diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
PreemptiveAI
This company develops artificial intelligence models that interpret physiological signals from wearable devices to predict health risks for healthcare providers and pharmaceutical companies.
Scipher Medicine
This company develops blood tests that use artificial intelligence to match autoimmune disease patients with effective therapies for clinicians and pharmaceutical partners.
Presymptom Health
This company develops AI-driven diagnostic tests and software that detect infection and sepsis in patients for use by healthcare providers and clinical labs.
Invigorate
This company provides a digital platform offering lifestyle coaching and resources to help patients manage autoimmune diseases.
Preview Health
This company develops an artificial intelligence molecular profiling platform to help pharmaceutical companies and clinicians detect diseases and evaluate drug responses through biological samples.
Predoc
The company develops an artificial intelligence platform to retrieve and analyse medical records for healthcare providers and clinical research organisations.
DETECTRA
This company develops a digital platform and AI algorithm to monitor joint inflammation through smartphone photos for patients with inflammatory arthritis and their rheumatologists.
20/20 BioLabs
This company develops AI-powered blood tests for the early detection and prevention of cancers and chronic diseases for individuals and healthcare providers.
